Home / Resource Library / PI3K Inhibitor Parsaclisib in Japanese Patients With Relapsed or Refractory Follicular Lymphoma

PI3K Inhibitor Parsaclisib in Japanese Patients With Relapsed or Refractory Follicular Lymphoma

Results of a study investigating parsaclisib for treatment of relapsed follicular lymphoma.